About UsProductsNewsClinical TrialCorporate RelationsResources

Recent News:

Aug 22, 2008
Ash Access Technology Completes AZEPTIC Trial for Zuragen® Injection

Feb 11, 2008
Dr. Stephen Ash Receives Lifetime Acheivement Award

Jan 25, 2008
AAT and AngioDynamics Release Centros™ Study Results

Jan 17, 2008
AAT Partners with AngioDynamics on New Dialysis Catheter

Ash Access Technology, Inc. is an integrated specialty pharmaceutical / medical device company engaged in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company has an advanced portfolio of innovative products targeting catheter-related bloodstream infections (CRBSI) and poor patency (blood flow) – the significant challenges associated with the use of both acute and chronic catheters for vascular access. more...